Tags

Type your tag names separated by a space and hit enter

The efficacy of "IOL-Vip Revolution" telescopic intraocular lens in age-related macular degeneration cases with senile cataract.
Eur J Ophthalmol. 2019 Nov; 29(6):615-620.EJ

Abstract

PURPOSE

To evaluate the efficacy of the IOL-Vip Revolution telescopic intraocular lens in age-related macular degeneration patients.

METHODS

A total of 13 eyes of 12 age-related macular degeneration patients with senile cataract were enrolled. Selection of the patients was done by means of a low vision diagnostic and rehabilitative program (IOL-Vip software) that evaluates residual visual function. After standard phacoemulsification surgery, the incision site was enlarged and the IOL-Vip Revolution system was implanted in the capsular bag. The outcome measures were best corrected visual acuity, contrast sensitivity, anterior chamber depth, endothelial cell density, central corneal thickness, and quality-of-life questionnaire.

RESULTS

The mean age of the subjects was 72.3 ± 8.5 years. The mean positive power of the intraocular lens was 59 ± 2 D and the negative intraocular lens power was standard (-46 D). Pre- and postoperative best corrected visual acuity were 1.08 ± 0.14 and 0.81 ± 0.16 logMAR in the operated eye and 1.13 ± 0.36 and 1.01 ± 0.40 logMAR in the unoperated eye, respectively. The best corrected visual acuity was increased significantly in both operated and unoperated eyes (p = 0.005 and 0.021, respectively). Quality of life and anterior chamber depth increased significantly (p = 0.018 and 0.008, respectively), while endothelial cell density decreased (p = 0.002). No significant differences were detected in central corneal thickness or contrast sensitivity (p = 0.133 and 0.684, respectively).

CONCLUSION

The results showed that IOL-Vip Revolution telescopic intraocular lens is a promising treatment option in age-related macular degeneration patients. The rehabilitation program may have an important role in the restored clinical results, which also provided visual improvement in the unoperated eyes.

Authors+Show Affiliations

Department of Ophthalmology, Izmir Katip Celebi University Atatürk Training and Research Hospital, Izmir, Turkey.Department of Ophthalmology, Faculty of Medicine, Ege University, Izmir, Turkey.Department of Ophthalmology, Faculty of Medicine, Ege University, Izmir, Turkey.Department of Ophthalmology, Faculty of Medicine, Ege University, Izmir, Turkey.Department of Ophthalmology, Faculty of Medicine, Ege University, Izmir, Turkey.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

30280594

Citation

Dag, Medine Yilmaz, et al. "The Efficacy of "IOL-Vip Revolution" Telescopic Intraocular Lens in Age-related Macular Degeneration Cases With Senile Cataract." European Journal of Ophthalmology, vol. 29, no. 6, 2019, pp. 615-620.
Dag MY, Afrashi F, Nalcaci S, et al. The efficacy of "IOL-Vip Revolution" telescopic intraocular lens in age-related macular degeneration cases with senile cataract. Eur J Ophthalmol. 2019;29(6):615-620.
Dag, M. Y., Afrashi, F., Nalcaci, S., Mentes, J., & Akkin, C. (2019). The efficacy of "IOL-Vip Revolution" telescopic intraocular lens in age-related macular degeneration cases with senile cataract. European Journal of Ophthalmology, 29(6), 615-620. https://doi.org/10.1177/1120672118803831
Dag MY, et al. The Efficacy of "IOL-Vip Revolution" Telescopic Intraocular Lens in Age-related Macular Degeneration Cases With Senile Cataract. Eur J Ophthalmol. 2019;29(6):615-620. PubMed PMID: 30280594.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The efficacy of "IOL-Vip Revolution" telescopic intraocular lens in age-related macular degeneration cases with senile cataract. AU - Dag,Medine Yilmaz, AU - Afrashi,Filiz, AU - Nalcaci,Serhad, AU - Mentes,Jale, AU - Akkin,Cezmi, Y1 - 2018/10/03/ PY - 2018/10/4/pubmed PY - 2019/12/18/medline PY - 2018/10/4/entrez KW - Age-related macular degeneration KW - IOL-Vip Revolution system KW - cataract KW - telescopic intraocular lens SP - 615 EP - 620 JF - European journal of ophthalmology JO - Eur J Ophthalmol VL - 29 IS - 6 N2 - PURPOSE: To evaluate the efficacy of the IOL-Vip Revolution telescopic intraocular lens in age-related macular degeneration patients. METHODS: A total of 13 eyes of 12 age-related macular degeneration patients with senile cataract were enrolled. Selection of the patients was done by means of a low vision diagnostic and rehabilitative program (IOL-Vip software) that evaluates residual visual function. After standard phacoemulsification surgery, the incision site was enlarged and the IOL-Vip Revolution system was implanted in the capsular bag. The outcome measures were best corrected visual acuity, contrast sensitivity, anterior chamber depth, endothelial cell density, central corneal thickness, and quality-of-life questionnaire. RESULTS: The mean age of the subjects was 72.3 ± 8.5 years. The mean positive power of the intraocular lens was 59 ± 2 D and the negative intraocular lens power was standard (-46 D). Pre- and postoperative best corrected visual acuity were 1.08 ± 0.14 and 0.81 ± 0.16 logMAR in the operated eye and 1.13 ± 0.36 and 1.01 ± 0.40 logMAR in the unoperated eye, respectively. The best corrected visual acuity was increased significantly in both operated and unoperated eyes (p = 0.005 and 0.021, respectively). Quality of life and anterior chamber depth increased significantly (p = 0.018 and 0.008, respectively), while endothelial cell density decreased (p = 0.002). No significant differences were detected in central corneal thickness or contrast sensitivity (p = 0.133 and 0.684, respectively). CONCLUSION: The results showed that IOL-Vip Revolution telescopic intraocular lens is a promising treatment option in age-related macular degeneration patients. The rehabilitation program may have an important role in the restored clinical results, which also provided visual improvement in the unoperated eyes. SN - 1724-6016 UR - https://www.unboundmedicine.com/medline/citation/30280594/The_efficacy_of_"IOL_Vip_Revolution"_telescopic_intraocular_lens_in_age_related_macular_degeneration_cases_with_senile_cataract_ L2 - https://journals.sagepub.com/doi/10.1177/1120672118803831?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -